• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性并发症的存在可区分糖尿病患者经颈静脉肝内门体分流术的院内结局。

Presence of chronic complications differentiates in-hospital outcomes of transjugular intrahepatic portosystemic shunt in patients with diabetes mellitus.

作者信息

Li Renxi, Lee SeungEun, Rienas William, Sarin Shawn

机构信息

The George Washington University School of Medicine and Health Sciences, WA, D.C., USA.

The George Washington University School of Medicine and Health Sciences, WA, D.C., USA.

出版信息

Am J Med Sci. 2025 Oct;370(4):358-364. doi: 10.1016/j.amjms.2025.07.011. Epub 2025 Jul 16.

DOI:10.1016/j.amjms.2025.07.011
PMID:40680932
Abstract

BACKGROUND

Transjugular intrahepatic portosystemic shunt (TIPS) is an interventional radiological procedure to reduce portal hypertension. Hyperglycemic state in diabetes mellitus (DM) is associated with vascular injuries that can lead to chronic complications, which is implicative of the extent/control of DM. This study aimed to use chronic complications as a marker for uncontrolled DM and examine major in-hospital outcomes after TIPS among DM patients with (DM-WCC) and without chronic complications (DM-WOCC).

MATERIALS

Patients who underwent TIPS were identified in the National Inpatient Sample (NIS) from Q4 2015-2020. DM-WCC and DM-WOCC were identified using the Elixhauser comorbidity measure. In-hospital post-TIPS outcomes between DM-WCC, DM-WOCC, and non-DM patients were compared using multivariable logistic regression.

RESULTS

NIS identified 1199 DM-WOCC, 1229 DM-WCC, and 4230 non-DM. Compared to non-DM, DM-WOCC had lower in-hospital mortality (aOR=0.661, 95 CI=0.493-0.885, p = 0.01) and renal complications (aOR=0.632, 95 CI=0.534-0.749, p < 0.01). Compared to non-DM, DM-WCC had higher renal complications (aOR=1.366, 95 CI=1.174-1.591, p < 0.01) and hepatic encephalopathy (HE; aOR=1.378, 95 CI=1.189-1.597, p < 0.01). Compared to DM-WOCC, DM-WCC had higher mortality (aOR=1.452, 95 CI=1.025-2.057, p = 0.04), renal complications (aOR=2.165, 95 CI=1.774-2.641, p < 0.01), and HE (aOR=1.247, 95 CI=1.045-1.487, p = 0.01). DM-WOCC had shorter length of stay and less total hospital costs than both DM-WCC and non-DM.

CONCLUSIONS

The presence of chronic complications in DM may differentiate the risk of complications after TIPS, where DM-WCC patients had worse outcomes, while DM-WOCC seems to be protective. Managing diabetic chronic complications may be helpful to avoid adverse outcomes after TIPS.

摘要

背景

经颈静脉肝内门体分流术(TIPS)是一种用于降低门静脉高压的介入放射学手术。糖尿病(DM)中的高血糖状态与可导致慢性并发症的血管损伤相关,这暗示了DM的程度/控制情况。本研究旨在将慢性并发症用作未控制DM的标志物,并检查伴有(DM-WCC)和不伴有慢性并发症(DM-WOCC)的DM患者在TIPS术后的主要院内结局。

材料

2015年第4季度至2020年期间,在国家住院患者样本(NIS)中识别出接受TIPS手术的患者。使用埃利克斯豪泽共病度量法识别DM-WCC和DM-WOCC。使用多变量逻辑回归比较DM-WCC、DM-WOCC和非DM患者TIPS术后的院内结局。

结果

NIS识别出1199例DM-WOCC、1229例DM-WCC和4230例非DM患者。与非DM患者相比,DM-WOCC的院内死亡率较低(调整后比值比[aOR]=0.661,95%置信区间[CI]=0.493-0.885,p=0.01),肾脏并发症发生率也较低(aOR=0.632,95%CI=0.534-0.749,p<0.01)。与非DM患者相比,DM-WCC的肾脏并发症发生率较高(aOR=1.366,95%CI=1.174-1.591,p<0.01),肝性脑病(HE)发生率也较高(aOR=1.378,CI=1.189-1.597,p<0.01)。与DM-WOCC相比,DM-WCC的死亡率较高(aOR=1.452,95%CI=1.025-2.057,p=0.04),肾脏并发症发生率较高(aOR=2.165,95%CI=1.774-2.641,p<0.01),HE发生率也较高(aOR=1.247,95%CI=1.045-1.487,p=0.01)。DM-WOCC的住院时间比DM-WCC和非DM患者都短,总住院费用也更低。

结论

DM中慢性并发症的存在可能会区分TIPS术后并发症的风险,其中DM-WCC患者的结局较差,而DM-WOCC似乎具有保护作用。控制糖尿病慢性并发症可能有助于避免TIPS术后的不良结局。

相似文献

1
Presence of chronic complications differentiates in-hospital outcomes of transjugular intrahepatic portosystemic shunt in patients with diabetes mellitus.慢性并发症的存在可区分糖尿病患者经颈静脉肝内门体分流术的院内结局。
Am J Med Sci. 2025 Oct;370(4):358-364. doi: 10.1016/j.amjms.2025.07.011. Epub 2025 Jul 16.
2
In-Hospital Outcomes of Patients with Hepatorenal Syndrome Who Underwent Transjugular Intrahepatic Portosystemic Shunt Procedure.接受经颈静脉肝内门体分流术的肝肾综合征患者的院内结局
Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09130-8.
3
Advanced chronic renal disease is an independent risk factor for inpatient mortality following transjugular intrahepatic portosystemic shunt procedure.晚期慢性肾脏疾病是经颈静脉肝内门体分流术治疗后住院患者死亡的独立危险因素。
Eur J Gastroenterol Hepatol. 2024 Mar 1;36(3):332-337. doi: 10.1097/MEG.0000000000002703. Epub 2023 Dec 27.
4
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
5
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
6
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.确定肝硬化合并静脉曲张出血患者经颈静脉肝内门体分流术后门静脉压力梯度的最佳测量时机和血流动力学目标。
J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22.
7
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术后的心血管风险评估及心脏失代偿的预测因素
World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740.
8
Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma-A systematic review and meta-analysis.经颈静脉肝内门体分流术治疗肝细胞癌的疗效和安全性:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Dec;43(6):1121-1135. doi: 10.1007/s12664-024-01646-7. Epub 2024 Aug 10.
9
Recurrent Portal Hypertension after Liver Transplant: Impact on Survival and the Role of Transjugular Intrahepatic Portosystemic Shunt Creation in Management.
J Vasc Interv Radiol. 2025 May;36(5):768-775. doi: 10.1016/j.jvir.2025.01.027. Epub 2025 Jan 21.
10
Indications and outcomes of transjugular intrahepatic portosystemic shunt insertion in two regional Australian hepatology centres.在澳大利亚两个地区的肝脏病中心经颈静脉肝内门体分流术的适应证和结果。
Intern Med J. 2024 Aug;54(8):1302-1309. doi: 10.1111/imj.16384. Epub 2024 Apr 23.